KalVista Pharmaceuticals (KALV) Net Margin (2014 - 2025)
KalVista Pharmaceuticals (KALV) reported Net Margin of 120.28% for Q3 2025, up 74.67% sequentially from 474.85% in Q2 2025.
KalVista Pharmaceuticals (KALV) Net Margin (2014 - 2025) Analysis & Trends
KalVista Pharmaceuticals (KALV) has 8 years of Net Margin data on file, last reported at 120.28% in Q3 2025.
- For the quarter ending Q3 2025, Net Margin changed N/A year-over-year to 120.28%; the trailing twelve-month figure through Jul 2025 stood at 253.66% (up 59510.0% YoY), and the FY2025 full-year result was 1667.75%, down 156242.0% from the prior year.
- Net Margin advanced to 120.28% in Q3 2025, from 474.85% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 120.28% in Q3 2025 to a low of 474.85% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -120.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -120.28% |
| Apr 30, 2025 | -474.85% |
| Apr 30, 2020 | -196.78% |
| Jan 31, 2020 | -920.48% |
| Oct 31, 2019 | -275.05% |
| Jul 31, 2019 | -288.25% |
| Apr 30, 2019 | -378.09% |
| Jan 31, 2019 | -161.03% |
| Oct 31, 2018 | -89.65% |
| Jul 31, 2018 | -194.92% |
| Apr 30, 2018 | -13.57% |
| Jan 31, 2018 | -224.54% |
| Oct 31, 2017 | -442.41% |
| Jul 31, 2017 | -5,133.33% |
| Apr 30, 2017 | -3,685.96% |
| Jan 31, 2017 | -3,167.34% |
| Oct 31, 2016 | -2,152.79% |
| Jul 31, 2016 | -458.97% |
| Mar 31, 2016 | -102,342.86% |
| Dec 31, 2015 | -80,800.00% |